nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ABCC1—Vandetanib—thyroid cancer	0.119	0.187	CbGbCtD
Progesterone—ABCC1—Epirubicin—thyroid cancer	0.0819	0.129	CbGbCtD
Progesterone—ABCB11—Doxorubicin—thyroid cancer	0.0613	0.0962	CbGbCtD
Progesterone—CYP1B1—Doxorubicin—thyroid cancer	0.0613	0.0962	CbGbCtD
Progesterone—ABCC1—Doxorubicin—thyroid cancer	0.0435	0.0683	CbGbCtD
Progesterone—CYP3A7—Sorafenib—thyroid cancer	0.0355	0.0557	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.0355	0.0557	CbGbCtD
Progesterone—CYP3A5—Sorafenib—thyroid cancer	0.0266	0.0418	CbGbCtD
Progesterone—CYP2C8—Sorafenib—thyroid cancer	0.0256	0.0401	CbGbCtD
Progesterone—CYP2C19—Sorafenib—thyroid cancer	0.0215	0.0337	CbGbCtD
Progesterone—CYP1A2—Sorafenib—thyroid cancer	0.0198	0.0311	CbGbCtD
Progesterone—CYP2C9—Sorafenib—thyroid cancer	0.0178	0.028	CbGbCtD
Progesterone—ABCB1—Sorafenib—thyroid cancer	0.0173	0.0272	CbGbCtD
Progesterone—CYP3A4—Vandetanib—thyroid cancer	0.0172	0.027	CbGbCtD
Progesterone—CYP2D6—Sorafenib—thyroid cancer	0.0163	0.0256	CbGbCtD
Progesterone—ABCB1—Doxorubicin—thyroid cancer	0.0105	0.0165	CbGbCtD
Progesterone—CYP3A4—Sorafenib—thyroid cancer	0.0104	0.0163	CbGbCtD
Progesterone—CYP2D6—Doxorubicin—thyroid cancer	0.0099	0.0155	CbGbCtD
Progesterone—CYP3A4—Doxorubicin—thyroid cancer	0.00629	0.00988	CbGbCtD
Progesterone—SHBG—neck—thyroid cancer	0.00161	0.0511	CbGeAlD
Progesterone—NR3C2—saliva-secreting gland—thyroid cancer	0.00121	0.0386	CbGeAlD
Progesterone—ESR1—neck—thyroid cancer	0.00113	0.036	CbGeAlD
Progesterone—SLC10A1—head—thyroid cancer	0.00104	0.0332	CbGeAlD
Progesterone—SLC22A3—saliva-secreting gland—thyroid cancer	0.00103	0.0329	CbGeAlD
Progesterone—CYP17A1—thyroid gland—thyroid cancer	0.00102	0.0326	CbGeAlD
Progesterone—SIGMAR1—saliva-secreting gland—thyroid cancer	0.000998	0.0318	CbGeAlD
Progesterone—NR3C2—trachea—thyroid cancer	0.000936	0.0298	CbGeAlD
Progesterone—OPRK1—head—thyroid cancer	0.000919	0.0293	CbGeAlD
Progesterone—CYP17A1—head—thyroid cancer	0.000909	0.0289	CbGeAlD
Progesterone—NR3C1—neck—thyroid cancer	0.000834	0.0266	CbGeAlD
Progesterone—SIGMAR1—trachea—thyroid cancer	0.00077	0.0245	CbGeAlD
Progesterone—SHBG—thyroid gland—thyroid cancer	0.000764	0.0243	CbGeAlD
Progesterone—NR3C2—thyroid gland—thyroid cancer	0.00074	0.0236	CbGeAlD
Progesterone—PGR—thyroid gland—thyroid cancer	0.000688	0.0219	CbGeAlD
Progesterone—ABCC1—trachea—thyroid cancer	0.000658	0.021	CbGeAlD
Progesterone—NR3C2—head—thyroid cancer	0.000657	0.0209	CbGeAlD
Progesterone—NR3C1—saliva-secreting gland—thyroid cancer	0.000651	0.0207	CbGeAlD
Progesterone—CYP17A1—lymph node—thyroid cancer	0.000637	0.0203	CbGeAlD
Progesterone—SLC22A3—thyroid gland—thyroid cancer	0.00063	0.0201	CbGeAlD
Progesterone—PGR—head—thyroid cancer	0.000611	0.0194	CbGeAlD
Progesterone—SIGMAR1—thyroid gland—thyroid cancer	0.000609	0.0194	CbGeAlD
Progesterone—SLC22A1—head—thyroid cancer	0.000585	0.0186	CbGeAlD
Progesterone—CYP1B1—thyroid gland—thyroid cancer	0.000579	0.0184	CbGeAlD
Progesterone—SLC22A3—head—thyroid cancer	0.000559	0.0178	CbGeAlD
Progesterone—AR—thyroid gland—thyroid cancer	0.000548	0.0175	CbGeAlD
Progesterone—ESR1—thyroid gland—thyroid cancer	0.000538	0.0171	CbGeAlD
Progesterone—ABCC1—thyroid gland—thyroid cancer	0.000521	0.0166	CbGeAlD
Progesterone—CYP1A1—trachea—thyroid cancer	0.000517	0.0165	CbGeAlD
Progesterone—CYP1B1—head—thyroid cancer	0.000514	0.0164	CbGeAlD
Progesterone—NR3C1—trachea—thyroid cancer	0.000502	0.016	CbGeAlD
Progesterone—AR—head—thyroid cancer	0.000487	0.0155	CbGeAlD
Progesterone—ESR1—head—thyroid cancer	0.000478	0.0152	CbGeAlD
Progesterone—NR3C2—lymph node—thyroid cancer	0.00046	0.0146	CbGeAlD
Progesterone—PGR—lymph node—thyroid cancer	0.000428	0.0136	CbGeAlD
Progesterone—CYP1A2—thyroid gland—thyroid cancer	0.000415	0.0132	CbGeAlD
Progesterone—CYP1A1—thyroid gland—thyroid cancer	0.000409	0.013	CbGeAlD
Progesterone—NR3C1—thyroid gland—thyroid cancer	0.000397	0.0126	CbGeAlD
Progesterone—SLC22A3—lymph node—thyroid cancer	0.000391	0.0125	CbGeAlD
Progesterone—SIGMAR1—lymph node—thyroid cancer	0.000378	0.012	CbGeAlD
Progesterone—CYP1A1—head—thyroid cancer	0.000363	0.0116	CbGeAlD
Progesterone—CYP1B1—lymph node—thyroid cancer	0.00036	0.0115	CbGeAlD
Progesterone—NR3C1—head—thyroid cancer	0.000352	0.0112	CbGeAlD
Progesterone—AR—lymph node—thyroid cancer	0.000341	0.0108	CbGeAlD
Progesterone—ESR1—lymph node—thyroid cancer	0.000334	0.0106	CbGeAlD
Progesterone—ABCC1—lymph node—thyroid cancer	0.000324	0.0103	CbGeAlD
Progesterone—Body temperature increased—Sorafenib—thyroid cancer	0.000272	0.00124	CcSEcCtD
Progesterone—ABCB1—trachea—thyroid cancer	0.000269	0.00856	CbGeAlD
Progesterone—Purpura—Epirubicin—thyroid cancer	0.000268	0.00123	CcSEcCtD
Progesterone—Vascular purpura—Doxorubicin—thyroid cancer	0.000268	0.00122	CcSEcCtD
Progesterone—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000267	0.00122	CcSEcCtD
Progesterone—Hepatic failure—Doxorubicin—thyroid cancer	0.000266	0.00122	CcSEcCtD
Progesterone—CYP2D6—head—thyroid cancer	0.000262	0.00835	CbGeAlD
Progesterone—Diplopia—Epirubicin—thyroid cancer	0.000259	0.00118	CcSEcCtD
Progesterone—Pain in extremity—Epirubicin—thyroid cancer	0.000259	0.00118	CcSEcCtD
Progesterone—Osteoarthritis—Epirubicin—thyroid cancer	0.000259	0.00118	CcSEcCtD
Progesterone—Hot flush—Doxorubicin—thyroid cancer	0.000256	0.00117	CcSEcCtD
Progesterone—Increased appetite—Doxorubicin—thyroid cancer	0.000255	0.00117	CcSEcCtD
Progesterone—Migraine—Epirubicin—thyroid cancer	0.000255	0.00117	CcSEcCtD
Progesterone—Affect lability—Epirubicin—thyroid cancer	0.000255	0.00117	CcSEcCtD
Progesterone—CYP1A1—lymph node—thyroid cancer	0.000254	0.0081	CbGeAlD
Progesterone—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000254	0.00116	CcSEcCtD
Progesterone—Hypersensitivity—Sorafenib—thyroid cancer	0.000253	0.00116	CcSEcCtD
Progesterone—Face oedema—Epirubicin—thyroid cancer	0.00025	0.00114	CcSEcCtD
Progesterone—Purpura—Doxorubicin—thyroid cancer	0.000248	0.00114	CcSEcCtD
Progesterone—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000247	0.00113	CcSEcCtD
Progesterone—Asthenia—Sorafenib—thyroid cancer	0.000247	0.00113	CcSEcCtD
Progesterone—NR3C1—lymph node—thyroid cancer	0.000247	0.00785	CbGeAlD
Progesterone—Mood swings—Epirubicin—thyroid cancer	0.000245	0.00112	CcSEcCtD
Progesterone—Pruritus—Sorafenib—thyroid cancer	0.000243	0.00111	CcSEcCtD
Progesterone—Diplopia—Doxorubicin—thyroid cancer	0.000239	0.0011	CcSEcCtD
Progesterone—Osteoarthritis—Doxorubicin—thyroid cancer	0.000239	0.0011	CcSEcCtD
Progesterone—Pain in extremity—Doxorubicin—thyroid cancer	0.000239	0.0011	CcSEcCtD
Progesterone—Liver function test abnormal—Epirubicin—thyroid cancer	0.000239	0.00109	CcSEcCtD
Progesterone—Migraine—Doxorubicin—thyroid cancer	0.000236	0.00108	CcSEcCtD
Progesterone—Affect lability—Doxorubicin—thyroid cancer	0.000236	0.00108	CcSEcCtD
Progesterone—Diarrhoea—Sorafenib—thyroid cancer	0.000235	0.00108	CcSEcCtD
Progesterone—Breast disorder—Epirubicin—thyroid cancer	0.000234	0.00107	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000233	0.00107	CcSEcCtD
Progesterone—Nasopharyngitis—Epirubicin—thyroid cancer	0.000231	0.00106	CcSEcCtD
Progesterone—Face oedema—Doxorubicin—thyroid cancer	0.000231	0.00106	CcSEcCtD
Progesterone—Gastritis—Epirubicin—thyroid cancer	0.000229	0.00105	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000228	0.00104	CcSEcCtD
Progesterone—Dizziness—Sorafenib—thyroid cancer	0.000227	0.00104	CcSEcCtD
Progesterone—Mood swings—Doxorubicin—thyroid cancer	0.000227	0.00104	CcSEcCtD
Progesterone—Abdominal distension—Epirubicin—thyroid cancer	0.000225	0.00103	CcSEcCtD
Progesterone—Asthma—Epirubicin—thyroid cancer	0.000224	0.00102	CcSEcCtD
Progesterone—Dysphagia—Epirubicin—thyroid cancer	0.000224	0.00102	CcSEcCtD
Progesterone—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000221	0.00101	CcSEcCtD
Progesterone—Vomiting—Sorafenib—thyroid cancer	0.000219	0.001	CcSEcCtD
Progesterone—Angina pectoris—Epirubicin—thyroid cancer	0.000218	0.000997	CcSEcCtD
Progesterone—Rash—Sorafenib—thyroid cancer	0.000217	0.000993	CcSEcCtD
Progesterone—Dermatitis—Sorafenib—thyroid cancer	0.000217	0.000992	CcSEcCtD
Progesterone—Breast disorder—Doxorubicin—thyroid cancer	0.000216	0.00099	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000216	0.000987	CcSEcCtD
Progesterone—Headache—Sorafenib—thyroid cancer	0.000215	0.000986	CcSEcCtD
Progesterone—Bronchitis—Epirubicin—thyroid cancer	0.000215	0.000984	CcSEcCtD
Progesterone—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000214	0.00098	CcSEcCtD
Progesterone—ABCB1—thyroid gland—thyroid cancer	0.000213	0.00677	CbGeAlD
Progesterone—Gastritis—Doxorubicin—thyroid cancer	0.000212	0.00097	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000211	0.000966	CcSEcCtD
Progesterone—Dysuria—Epirubicin—thyroid cancer	0.000209	0.000957	CcSEcCtD
Progesterone—Abdominal distension—Doxorubicin—thyroid cancer	0.000208	0.000953	CcSEcCtD
Progesterone—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000208	0.000951	CcSEcCtD
Progesterone—Asthma—Doxorubicin—thyroid cancer	0.000207	0.000947	CcSEcCtD
Progesterone—Dysphagia—Doxorubicin—thyroid cancer	0.000207	0.000947	CcSEcCtD
Progesterone—Pollakiuria—Epirubicin—thyroid cancer	0.000207	0.000945	CcSEcCtD
Progesterone—Nausea—Sorafenib—thyroid cancer	0.000204	0.000935	CcSEcCtD
Progesterone—Weight increased—Epirubicin—thyroid cancer	0.000203	0.000931	CcSEcCtD
Progesterone—Weight decreased—Epirubicin—thyroid cancer	0.000202	0.000926	CcSEcCtD
Progesterone—Hyperglycaemia—Epirubicin—thyroid cancer	0.000202	0.000923	CcSEcCtD
Progesterone—Angina pectoris—Doxorubicin—thyroid cancer	0.000201	0.000922	CcSEcCtD
Progesterone—Pneumonia—Epirubicin—thyroid cancer	0.0002	0.000918	CcSEcCtD
Progesterone—Drowsiness—Epirubicin—thyroid cancer	0.000199	0.000912	CcSEcCtD
Progesterone—Infestation—Epirubicin—thyroid cancer	0.000199	0.000912	CcSEcCtD
Progesterone—Infestation NOS—Epirubicin—thyroid cancer	0.000199	0.000912	CcSEcCtD
Progesterone—Bronchitis—Doxorubicin—thyroid cancer	0.000199	0.000911	CcSEcCtD
Progesterone—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000195	0.000894	CcSEcCtD
Progesterone—Jaundice—Epirubicin—thyroid cancer	0.000194	0.000889	CcSEcCtD
Progesterone—Conjunctivitis—Epirubicin—thyroid cancer	0.000194	0.000887	CcSEcCtD
Progesterone—Urinary tract infection—Epirubicin—thyroid cancer	0.000194	0.000887	CcSEcCtD
Progesterone—Dysuria—Doxorubicin—thyroid cancer	0.000193	0.000885	CcSEcCtD
Progesterone—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000192	0.00088	CcSEcCtD
Progesterone—Pollakiuria—Doxorubicin—thyroid cancer	0.000191	0.000875	CcSEcCtD
Progesterone—ABCB1—head—thyroid cancer	0.000189	0.00601	CbGeAlD
Progesterone—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000189	0.000863	CcSEcCtD
Progesterone—Weight increased—Doxorubicin—thyroid cancer	0.000188	0.000862	CcSEcCtD
Progesterone—Weight decreased—Doxorubicin—thyroid cancer	0.000187	0.000857	CcSEcCtD
Progesterone—Sinusitis—Epirubicin—thyroid cancer	0.000187	0.000856	CcSEcCtD
Progesterone—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000187	0.000854	CcSEcCtD
Progesterone—Pneumonia—Doxorubicin—thyroid cancer	0.000185	0.000849	CcSEcCtD
Progesterone—Drowsiness—Doxorubicin—thyroid cancer	0.000184	0.000844	CcSEcCtD
Progesterone—Infestation—Doxorubicin—thyroid cancer	0.000184	0.000844	CcSEcCtD
Progesterone—Infestation NOS—Doxorubicin—thyroid cancer	0.000184	0.000844	CcSEcCtD
Progesterone—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000181	0.000828	CcSEcCtD
Progesterone—Haemoglobin—Epirubicin—thyroid cancer	0.00018	0.000823	CcSEcCtD
Progesterone—Jaundice—Doxorubicin—thyroid cancer	0.00018	0.000823	CcSEcCtD
Progesterone—Rhinitis—Epirubicin—thyroid cancer	0.000179	0.000821	CcSEcCtD
Progesterone—Urinary tract infection—Doxorubicin—thyroid cancer	0.000179	0.000821	CcSEcCtD
Progesterone—Conjunctivitis—Doxorubicin—thyroid cancer	0.000179	0.000821	CcSEcCtD
Progesterone—Haemorrhage—Epirubicin—thyroid cancer	0.000179	0.000819	CcSEcCtD
Progesterone—Hepatitis—Epirubicin—thyroid cancer	0.000179	0.000819	CcSEcCtD
Progesterone—Pharyngitis—Epirubicin—thyroid cancer	0.000178	0.000813	CcSEcCtD
Progesterone—Urinary tract disorder—Epirubicin—thyroid cancer	0.000177	0.000809	CcSEcCtD
Progesterone—Oedema peripheral—Epirubicin—thyroid cancer	0.000176	0.000807	CcSEcCtD
Progesterone—Connective tissue disorder—Epirubicin—thyroid cancer	0.000176	0.000805	CcSEcCtD
Progesterone—Urethral disorder—Epirubicin—thyroid cancer	0.000175	0.000803	CcSEcCtD
Progesterone—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000174	0.000798	CcSEcCtD
Progesterone—Sinusitis—Doxorubicin—thyroid cancer	0.000173	0.000792	CcSEcCtD
Progesterone—Visual impairment—Epirubicin—thyroid cancer	0.000172	0.000789	CcSEcCtD
Progesterone—Erythema multiforme—Epirubicin—thyroid cancer	0.000169	0.000774	CcSEcCtD
Progesterone—Eye disorder—Epirubicin—thyroid cancer	0.000167	0.000765	CcSEcCtD
Progesterone—Tinnitus—Epirubicin—thyroid cancer	0.000167	0.000764	CcSEcCtD
Progesterone—Haemoglobin—Doxorubicin—thyroid cancer	0.000166	0.000762	CcSEcCtD
Progesterone—Cardiac disorder—Epirubicin—thyroid cancer	0.000166	0.00076	CcSEcCtD
Progesterone—Rhinitis—Doxorubicin—thyroid cancer	0.000166	0.00076	CcSEcCtD
Progesterone—Haemorrhage—Doxorubicin—thyroid cancer	0.000166	0.000758	CcSEcCtD
Progesterone—Hepatitis—Doxorubicin—thyroid cancer	0.000166	0.000758	CcSEcCtD
Progesterone—Pharyngitis—Doxorubicin—thyroid cancer	0.000164	0.000752	CcSEcCtD
Progesterone—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000164	0.000748	CcSEcCtD
Progesterone—Oedema peripheral—Doxorubicin—thyroid cancer	0.000163	0.000747	CcSEcCtD
Progesterone—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000163	0.000745	CcSEcCtD
Progesterone—Angiopathy—Epirubicin—thyroid cancer	0.000162	0.000743	CcSEcCtD
Progesterone—Urethral disorder—Doxorubicin—thyroid cancer	0.000162	0.000743	CcSEcCtD
Progesterone—Immune system disorder—Epirubicin—thyroid cancer	0.000162	0.00074	CcSEcCtD
Progesterone—Mediastinal disorder—Epirubicin—thyroid cancer	0.000161	0.000738	CcSEcCtD
Progesterone—Visual impairment—Doxorubicin—thyroid cancer	0.00016	0.00073	CcSEcCtD
Progesterone—Alopecia—Epirubicin—thyroid cancer	0.000158	0.000724	CcSEcCtD
Progesterone—Mental disorder—Epirubicin—thyroid cancer	0.000157	0.000718	CcSEcCtD
Progesterone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000157	0.000717	CcSEcCtD
Progesterone—Erythema—Epirubicin—thyroid cancer	0.000156	0.000713	CcSEcCtD
Progesterone—Malnutrition—Epirubicin—thyroid cancer	0.000156	0.000713	CcSEcCtD
Progesterone—Eye disorder—Doxorubicin—thyroid cancer	0.000155	0.000708	CcSEcCtD
Progesterone—Tinnitus—Doxorubicin—thyroid cancer	0.000154	0.000707	CcSEcCtD
Progesterone—Cardiac disorder—Doxorubicin—thyroid cancer	0.000154	0.000703	CcSEcCtD
Progesterone—Flatulence—Epirubicin—thyroid cancer	0.000153	0.000703	CcSEcCtD
Progesterone—Tension—Epirubicin—thyroid cancer	0.000153	0.0007	CcSEcCtD
Progesterone—Nervousness—Epirubicin—thyroid cancer	0.000151	0.000693	CcSEcCtD
Progesterone—Back pain—Epirubicin—thyroid cancer	0.000151	0.00069	CcSEcCtD
Progesterone—Angiopathy—Doxorubicin—thyroid cancer	0.00015	0.000688	CcSEcCtD
Progesterone—Muscle spasms—Epirubicin—thyroid cancer	0.00015	0.000686	CcSEcCtD
Progesterone—Immune system disorder—Doxorubicin—thyroid cancer	0.00015	0.000685	CcSEcCtD
Progesterone—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000149	0.000683	CcSEcCtD
Progesterone—Vision blurred—Epirubicin—thyroid cancer	0.000147	0.000672	CcSEcCtD
Progesterone—Alopecia—Doxorubicin—thyroid cancer	0.000146	0.00067	CcSEcCtD
Progesterone—Mental disorder—Doxorubicin—thyroid cancer	0.000145	0.000664	CcSEcCtD
Progesterone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000145	0.000662	CcSEcCtD
Progesterone—Malnutrition—Doxorubicin—thyroid cancer	0.000144	0.00066	CcSEcCtD
Progesterone—Erythema—Doxorubicin—thyroid cancer	0.000144	0.00066	CcSEcCtD
Progesterone—Anaemia—Epirubicin—thyroid cancer	0.000144	0.000659	CcSEcCtD
Progesterone—Flatulence—Doxorubicin—thyroid cancer	0.000142	0.00065	CcSEcCtD
Progesterone—Tension—Doxorubicin—thyroid cancer	0.000141	0.000647	CcSEcCtD
Progesterone—Malaise—Epirubicin—thyroid cancer	0.00014	0.000643	CcSEcCtD
Progesterone—Nervousness—Doxorubicin—thyroid cancer	0.00014	0.000641	CcSEcCtD
Progesterone—Vertigo—Epirubicin—thyroid cancer	0.00014	0.000641	CcSEcCtD
Progesterone—Syncope—Epirubicin—thyroid cancer	0.00014	0.000639	CcSEcCtD
Progesterone—Back pain—Doxorubicin—thyroid cancer	0.000139	0.000638	CcSEcCtD
Progesterone—Muscle spasms—Doxorubicin—thyroid cancer	0.000139	0.000634	CcSEcCtD
Progesterone—Palpitations—Epirubicin—thyroid cancer	0.000138	0.00063	CcSEcCtD
Progesterone—Loss of consciousness—Epirubicin—thyroid cancer	0.000137	0.000627	CcSEcCtD
Progesterone—Cough—Epirubicin—thyroid cancer	0.000136	0.000622	CcSEcCtD
Progesterone—Vision blurred—Doxorubicin—thyroid cancer	0.000136	0.000622	CcSEcCtD
Progesterone—Convulsion—Epirubicin—thyroid cancer	0.000135	0.000618	CcSEcCtD
Progesterone—Hypertension—Epirubicin—thyroid cancer	0.000134	0.000616	CcSEcCtD
Progesterone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000134	0.000612	CcSEcCtD
Progesterone—Anaemia—Doxorubicin—thyroid cancer	0.000133	0.00061	CcSEcCtD
Progesterone—Chest pain—Epirubicin—thyroid cancer	0.000133	0.000607	CcSEcCtD
Progesterone—Arthralgia—Epirubicin—thyroid cancer	0.000133	0.000607	CcSEcCtD
Progesterone—Myalgia—Epirubicin—thyroid cancer	0.000133	0.000607	CcSEcCtD
Progesterone—Anxiety—Epirubicin—thyroid cancer	0.000132	0.000605	CcSEcCtD
Progesterone—ABCB1—lymph node—thyroid cancer	0.000132	0.0042	CbGeAlD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000132	0.000603	CcSEcCtD
Progesterone—Discomfort—Epirubicin—thyroid cancer	0.000131	0.0006	CcSEcCtD
Progesterone—Malaise—Doxorubicin—thyroid cancer	0.00013	0.000595	CcSEcCtD
Progesterone—Dry mouth—Epirubicin—thyroid cancer	0.00013	0.000594	CcSEcCtD
Progesterone—Vertigo—Doxorubicin—thyroid cancer	0.000129	0.000593	CcSEcCtD
Progesterone—Syncope—Doxorubicin—thyroid cancer	0.000129	0.000592	CcSEcCtD
Progesterone—Confusional state—Epirubicin—thyroid cancer	0.000128	0.000587	CcSEcCtD
Progesterone—Palpitations—Doxorubicin—thyroid cancer	0.000127	0.000583	CcSEcCtD
Progesterone—Oedema—Epirubicin—thyroid cancer	0.000127	0.000582	CcSEcCtD
Progesterone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000127	0.000582	CcSEcCtD
Progesterone—Loss of consciousness—Doxorubicin—thyroid cancer	0.000127	0.00058	CcSEcCtD
Progesterone—Infection—Epirubicin—thyroid cancer	0.000126	0.000578	CcSEcCtD
Progesterone—Cough—Doxorubicin—thyroid cancer	0.000126	0.000576	CcSEcCtD
Progesterone—Shock—Epirubicin—thyroid cancer	0.000125	0.000573	CcSEcCtD
Progesterone—Convulsion—Doxorubicin—thyroid cancer	0.000125	0.000572	CcSEcCtD
Progesterone—Nervous system disorder—Epirubicin—thyroid cancer	0.000125	0.000571	CcSEcCtD
Progesterone—Hypertension—Doxorubicin—thyroid cancer	0.000124	0.00057	CcSEcCtD
Progesterone—Tachycardia—Epirubicin—thyroid cancer	0.000124	0.000568	CcSEcCtD
Progesterone—Skin disorder—Epirubicin—thyroid cancer	0.000123	0.000565	CcSEcCtD
Progesterone—Hyperhidrosis—Epirubicin—thyroid cancer	0.000123	0.000563	CcSEcCtD
Progesterone—Myalgia—Doxorubicin—thyroid cancer	0.000123	0.000562	CcSEcCtD
Progesterone—Arthralgia—Doxorubicin—thyroid cancer	0.000123	0.000562	CcSEcCtD
Progesterone—Chest pain—Doxorubicin—thyroid cancer	0.000123	0.000562	CcSEcCtD
Progesterone—Anxiety—Doxorubicin—thyroid cancer	0.000122	0.00056	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000122	0.000558	CcSEcCtD
Progesterone—Discomfort—Doxorubicin—thyroid cancer	0.000121	0.000555	CcSEcCtD
Progesterone—Anorexia—Epirubicin—thyroid cancer	0.000121	0.000555	CcSEcCtD
Progesterone—Dry mouth—Doxorubicin—thyroid cancer	0.00012	0.000549	CcSEcCtD
Progesterone—Hypotension—Epirubicin—thyroid cancer	0.000119	0.000544	CcSEcCtD
Progesterone—Confusional state—Doxorubicin—thyroid cancer	0.000119	0.000543	CcSEcCtD
Progesterone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000118	0.000538	CcSEcCtD
Progesterone—Oedema—Doxorubicin—thyroid cancer	0.000118	0.000538	CcSEcCtD
Progesterone—Infection—Doxorubicin—thyroid cancer	0.000117	0.000535	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000116	0.00053	CcSEcCtD
Progesterone—Shock—Doxorubicin—thyroid cancer	0.000116	0.00053	CcSEcCtD
Progesterone—Nervous system disorder—Doxorubicin—thyroid cancer	0.000115	0.000528	CcSEcCtD
Progesterone—Insomnia—Epirubicin—thyroid cancer	0.000115	0.000526	CcSEcCtD
Progesterone—Tachycardia—Doxorubicin—thyroid cancer	0.000115	0.000526	CcSEcCtD
Progesterone—Skin disorder—Doxorubicin—thyroid cancer	0.000114	0.000523	CcSEcCtD
Progesterone—Paraesthesia—Epirubicin—thyroid cancer	0.000114	0.000523	CcSEcCtD
Progesterone—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000114	0.000521	CcSEcCtD
Progesterone—Dyspnoea—Epirubicin—thyroid cancer	0.000113	0.000519	CcSEcCtD
Progesterone—Somnolence—Epirubicin—thyroid cancer	0.000113	0.000517	CcSEcCtD
Progesterone—Anorexia—Doxorubicin—thyroid cancer	0.000112	0.000513	CcSEcCtD
Progesterone—Dyspepsia—Epirubicin—thyroid cancer	0.000112	0.000512	CcSEcCtD
Progesterone—Decreased appetite—Epirubicin—thyroid cancer	0.000111	0.000506	CcSEcCtD
Progesterone—Hypotension—Doxorubicin—thyroid cancer	0.00011	0.000503	CcSEcCtD
Progesterone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00011	0.000502	CcSEcCtD
Progesterone—Fatigue—Epirubicin—thyroid cancer	0.00011	0.000502	CcSEcCtD
Progesterone—Constipation—Epirubicin—thyroid cancer	0.000109	0.000498	CcSEcCtD
Progesterone—Pain—Epirubicin—thyroid cancer	0.000109	0.000498	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000107	0.000491	CcSEcCtD
Progesterone—Insomnia—Doxorubicin—thyroid cancer	0.000106	0.000487	CcSEcCtD
Progesterone—Paraesthesia—Doxorubicin—thyroid cancer	0.000106	0.000484	CcSEcCtD
Progesterone—Dyspnoea—Doxorubicin—thyroid cancer	0.000105	0.00048	CcSEcCtD
Progesterone—Feeling abnormal—Epirubicin—thyroid cancer	0.000105	0.00048	CcSEcCtD
Progesterone—Somnolence—Doxorubicin—thyroid cancer	0.000105	0.000479	CcSEcCtD
Progesterone—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000104	0.000476	CcSEcCtD
Progesterone—Dyspepsia—Doxorubicin—thyroid cancer	0.000104	0.000474	CcSEcCtD
Progesterone—Decreased appetite—Doxorubicin—thyroid cancer	0.000102	0.000468	CcSEcCtD
Progesterone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000102	0.000465	CcSEcCtD
Progesterone—Fatigue—Doxorubicin—thyroid cancer	0.000101	0.000464	CcSEcCtD
Progesterone—Urticaria—Epirubicin—thyroid cancer	0.000101	0.000462	CcSEcCtD
Progesterone—Constipation—Doxorubicin—thyroid cancer	0.000101	0.00046	CcSEcCtD
Progesterone—Pain—Doxorubicin—thyroid cancer	0.000101	0.00046	CcSEcCtD
Progesterone—Abdominal pain—Epirubicin—thyroid cancer	0.0001	0.00046	CcSEcCtD
Progesterone—Body temperature increased—Epirubicin—thyroid cancer	0.0001	0.00046	CcSEcCtD
Progesterone—Feeling abnormal—Doxorubicin—thyroid cancer	9.69e-05	0.000444	CcSEcCtD
Progesterone—Gastrointestinal pain—Doxorubicin—thyroid cancer	9.62e-05	0.00044	CcSEcCtD
Progesterone—Hypersensitivity—Epirubicin—thyroid cancer	9.37e-05	0.000429	CcSEcCtD
Progesterone—Urticaria—Doxorubicin—thyroid cancer	9.34e-05	0.000428	CcSEcCtD
Progesterone—Body temperature increased—Doxorubicin—thyroid cancer	9.3e-05	0.000426	CcSEcCtD
Progesterone—Abdominal pain—Doxorubicin—thyroid cancer	9.3e-05	0.000426	CcSEcCtD
Progesterone—Asthenia—Epirubicin—thyroid cancer	9.12e-05	0.000418	CcSEcCtD
Progesterone—Pruritus—Epirubicin—thyroid cancer	8.99e-05	0.000412	CcSEcCtD
Progesterone—Diarrhoea—Epirubicin—thyroid cancer	8.7e-05	0.000398	CcSEcCtD
Progesterone—Hypersensitivity—Doxorubicin—thyroid cancer	8.67e-05	0.000397	CcSEcCtD
Progesterone—Asthenia—Doxorubicin—thyroid cancer	8.44e-05	0.000386	CcSEcCtD
Progesterone—Dizziness—Epirubicin—thyroid cancer	8.41e-05	0.000385	CcSEcCtD
Progesterone—Pruritus—Doxorubicin—thyroid cancer	8.32e-05	0.000381	CcSEcCtD
Progesterone—Vomiting—Epirubicin—thyroid cancer	8.08e-05	0.00037	CcSEcCtD
Progesterone—Diarrhoea—Doxorubicin—thyroid cancer	8.05e-05	0.000368	CcSEcCtD
Progesterone—Rash—Epirubicin—thyroid cancer	8.02e-05	0.000367	CcSEcCtD
Progesterone—Dermatitis—Epirubicin—thyroid cancer	8.01e-05	0.000367	CcSEcCtD
Progesterone—Headache—Epirubicin—thyroid cancer	7.96e-05	0.000365	CcSEcCtD
Progesterone—Dizziness—Doxorubicin—thyroid cancer	7.78e-05	0.000356	CcSEcCtD
Progesterone—Nausea—Epirubicin—thyroid cancer	7.55e-05	0.000346	CcSEcCtD
Progesterone—Vomiting—Doxorubicin—thyroid cancer	7.48e-05	0.000342	CcSEcCtD
Progesterone—Rash—Doxorubicin—thyroid cancer	7.42e-05	0.00034	CcSEcCtD
Progesterone—Dermatitis—Doxorubicin—thyroid cancer	7.41e-05	0.000339	CcSEcCtD
Progesterone—Headache—Doxorubicin—thyroid cancer	7.37e-05	0.000337	CcSEcCtD
Progesterone—Nausea—Doxorubicin—thyroid cancer	6.99e-05	0.00032	CcSEcCtD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.11e-05	0.000276	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	3.1e-05	0.000274	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	3.09e-05	0.000274	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTCH1—thyroid cancer	3.08e-05	0.000273	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—HPGD—thyroid cancer	3.06e-05	0.000271	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.04e-05	0.000269	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—RXRA—thyroid cancer	3.02e-05	0.000268	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—HPGD—thyroid cancer	2.99e-05	0.000265	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CHST14—thyroid cancer	2.96e-05	0.000262	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.94e-05	0.00026	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—TPR—thyroid cancer	2.93e-05	0.000259	CbGpPWpGaD
Progesterone—ABCC1—Disease—CDK1—thyroid cancer	2.92e-05	0.000259	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.9e-05	0.000257	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—TPR—thyroid cancer	2.89e-05	0.000256	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	2.89e-05	0.000255	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	2.88e-05	0.000255	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.86e-05	0.000253	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	2.84e-05	0.000251	CbGpPWpGaD
Progesterone—PGR—Gene Expression—PPARG—thyroid cancer	2.82e-05	0.00025	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—HPGD—thyroid cancer	2.82e-05	0.00025	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SST—thyroid cancer	2.82e-05	0.000249	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—HPGD—thyroid cancer	2.79e-05	0.000247	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.78e-05	0.000247	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.74e-05	0.000243	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.74e-05	0.000243	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TSHR—thyroid cancer	2.71e-05	0.00024	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CALCA—thyroid cancer	2.71e-05	0.00024	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—SLC5A5—thyroid cancer	2.7e-05	0.000239	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	2.7e-05	0.000239	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	2.67e-05	0.000236	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—RXRA—thyroid cancer	2.63e-05	0.000232	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—SLC5A5—thyroid cancer	2.61e-05	0.000231	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.61e-05	0.000231	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—RXRA—thyroid cancer	2.59e-05	0.000229	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MEN1—thyroid cancer	2.55e-05	0.000226	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PTGS2—thyroid cancer	2.55e-05	0.000226	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.53e-05	0.000224	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.52e-05	0.000223	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRG1—thyroid cancer	2.52e-05	0.000223	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.49e-05	0.00022	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CDK1—thyroid cancer	2.45e-05	0.000217	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.45e-05	0.000217	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—NDUFA13—thyroid cancer	2.43e-05	0.000215	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—HPGD—thyroid cancer	2.39e-05	0.000211	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PPARG—thyroid cancer	2.38e-05	0.00021	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—SLC5A5—thyroid cancer	2.36e-05	0.000209	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—SLC5A5—thyroid cancer	2.35e-05	0.000208	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRG1—thyroid cancer	2.34e-05	0.000208	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTCH1—thyroid cancer	2.31e-05	0.000204	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.31e-05	0.000204	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CHST14—thyroid cancer	2.29e-05	0.000202	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—TPR—thyroid cancer	2.28e-05	0.000202	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—RXRA—thyroid cancer	2.27e-05	0.000201	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.27e-05	0.000201	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TERT—thyroid cancer	2.26e-05	0.0002	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	2.24e-05	0.000198	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PTEN—thyroid cancer	2.22e-05	0.000197	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—HRAS—thyroid cancer	2.22e-05	0.000197	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.21e-05	0.000196	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—RXRA—thyroid cancer	2.2e-05	0.000194	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—SLC5A5—thyroid cancer	2.19e-05	0.000194	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—SLC5A5—thyroid cancer	2.16e-05	0.000191	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HIF1A—thyroid cancer	2.16e-05	0.000191	CbGpPWpGaD
Progesterone—AR—Gene Expression—PPARG—thyroid cancer	2.15e-05	0.000191	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—TPR—thyroid cancer	2.15e-05	0.00019	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.14e-05	0.000189	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PRKAR1A—thyroid cancer	2.12e-05	0.000187	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SST—thyroid cancer	2.11e-05	0.000187	CbGpPWpGaD
Progesterone—ABCC1—Disease—TERT—thyroid cancer	2.11e-05	0.000186	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—HRAS—thyroid cancer	2.07e-05	0.000183	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CALCA—thyroid cancer	2.03e-05	0.00018	CbGpPWpGaD
Progesterone—ABCC1—Disease—HIF1A—thyroid cancer	2.01e-05	0.000178	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PPARG—thyroid cancer	1.99e-05	0.000176	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—RXRA—thyroid cancer	1.98e-05	0.000175	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—RXRA—thyroid cancer	1.98e-05	0.000175	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—TPR—thyroid cancer	1.97e-05	0.000175	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRG1—thyroid cancer	1.97e-05	0.000174	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	1.94e-05	0.000172	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.94e-05	0.000171	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.93e-05	0.000171	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.92e-05	0.00017	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PPARG—thyroid cancer	1.91e-05	0.000169	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—thyroid cancer	1.87e-05	0.000166	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—RXRA—thyroid cancer	1.84e-05	0.000163	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—HPGD—thyroid cancer	1.84e-05	0.000163	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CDK1—thyroid cancer	1.84e-05	0.000163	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—AKT1—thyroid cancer	1.83e-05	0.000162	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—RXRA—thyroid cancer	1.82e-05	0.000161	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—BRAF—thyroid cancer	1.79e-05	0.000158	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TERT—thyroid cancer	1.77e-05	0.000157	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—TPR—thyroid cancer	1.76e-05	0.000156	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.76e-05	0.000156	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.73e-05	0.000153	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—TPR—thyroid cancer	1.72e-05	0.000152	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.72e-05	0.000152	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—SLC5A5—thyroid cancer	1.7e-05	0.000151	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HIF1A—thyroid cancer	1.69e-05	0.00015	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	1.69e-05	0.00015	CbGpPWpGaD
Progesterone—ABCC1—Disease—BRAF—thyroid cancer	1.67e-05	0.000148	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—PPARG—thyroid cancer	1.66e-05	0.000147	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—PPARG—thyroid cancer	1.63e-05	0.000145	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTEN—thyroid cancer	1.63e-05	0.000144	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—TPR—thyroid cancer	1.62e-05	0.000143	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—SLC5A5—thyroid cancer	1.61e-05	0.000143	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—TPR—thyroid cancer	1.6e-05	0.000142	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.59e-05	0.000141	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.58e-05	0.00014	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.57e-05	0.000139	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—thyroid cancer	1.57e-05	0.000139	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.51e-05	0.000134	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—thyroid cancer	1.5e-05	0.000133	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—NRAS—thyroid cancer	1.49e-05	0.000132	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRG1—thyroid cancer	1.48e-05	0.000131	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	1.48e-05	0.000131	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.45e-05	0.000128	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PPARG—thyroid cancer	1.43e-05	0.000127	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—RXRA—thyroid cancer	1.43e-05	0.000127	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.43e-05	0.000127	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—BRAF—thyroid cancer	1.4e-05	0.000124	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PPARG—thyroid cancer	1.39e-05	0.000123	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.38e-05	0.000122	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—TPR—thyroid cancer	1.37e-05	0.000121	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTEN—thyroid cancer	1.37e-05	0.000121	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—RXRA—thyroid cancer	1.35e-05	0.00012	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	1.35e-05	0.000119	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—thyroid cancer	1.35e-05	0.000119	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TERT—thyroid cancer	1.33e-05	0.000117	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—SLC5A5—thyroid cancer	1.32e-05	0.000117	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.32e-05	0.000116	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTEN—thyroid cancer	1.31e-05	0.000116	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CCND1—thyroid cancer	1.31e-05	0.000116	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.000114	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—KRAS—thyroid cancer	1.28e-05	0.000114	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—AKT1—thyroid cancer	1.28e-05	0.000113	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HIF1A—thyroid cancer	1.27e-05	0.000112	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTEN—thyroid cancer	1.26e-05	0.000112	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PPARG—thyroid cancer	1.25e-05	0.000111	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PPARG—thyroid cancer	1.25e-05	0.000111	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—RXRA—thyroid cancer	1.24e-05	0.00011	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.23e-05	0.000109	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.22e-05	0.000108	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000107	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.21e-05	0.000107	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—SLC5A5—thyroid cancer	1.2e-05	0.000106	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTEN—thyroid cancer	1.17e-05	0.000104	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PPARG—thyroid cancer	1.16e-05	0.000103	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PPARG—thyroid cancer	1.15e-05	0.000101	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—thyroid cancer	1.13e-05	9.99e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.13e-05	9.97e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—thyroid cancer	1.12e-05	9.95e-05	CbGpPWpGaD
Progesterone—PGR—Gene Expression—AKT1—thyroid cancer	1.12e-05	9.89e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—RXRA—thyroid cancer	1.11e-05	9.8e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—thyroid cancer	1.09e-05	9.66e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—thyroid cancer	1.09e-05	9.65e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—RXRA—thyroid cancer	1.08e-05	9.56e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.08e-05	9.53e-05	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKT1—thyroid cancer	1.06e-05	9.39e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—TPR—thyroid cancer	1.06e-05	9.37e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—thyroid cancer	1.05e-05	9.29e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—thyroid cancer	1.05e-05	9.28e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.04e-05	9.22e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.03e-05	9.09e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CCND1—thyroid cancer	1.02e-05	9.05e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—RXRA—thyroid cancer	1.02e-05	9.01e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—RXRA—thyroid cancer	1.01e-05	8.94e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTEN—thyroid cancer	9.87e-06	8.74e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—thyroid cancer	9.84e-06	8.71e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTEN—thyroid cancer	9.84e-06	8.71e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—thyroid cancer	9.82e-06	8.7e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.81e-06	8.69e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—thyroid cancer	9.67e-06	8.57e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKT1—thyroid cancer	9.63e-06	8.52e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.62e-06	8.52e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTEN—thyroid cancer	9.51e-06	8.42e-05	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—AKT1—thyroid cancer	9.4e-06	8.32e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—thyroid cancer	9.15e-06	8.11e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PPARG—thyroid cancer	9.04e-06	8e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—thyroid cancer	9.02e-06	7.98e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—thyroid cancer	9.02e-06	7.98e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—thyroid cancer	8.8e-06	7.8e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—RXRA—thyroid cancer	8.62e-06	7.64e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—thyroid cancer	8.6e-06	7.61e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTEN—thyroid cancer	8.58e-06	7.6e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTEN—thyroid cancer	8.56e-06	7.58e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PPARG—thyroid cancer	8.54e-06	7.56e-05	CbGpPWpGaD
Progesterone—AR—Gene Expression—AKT1—thyroid cancer	8.51e-06	7.53e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.39e-06	7.43e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—thyroid cancer	8.22e-06	7.28e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTEN—thyroid cancer	7.98e-06	7.07e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—SLC5A5—thyroid cancer	7.92e-06	7.01e-05	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—AKT1—thyroid cancer	7.87e-06	6.97e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTEN—thyroid cancer	7.86e-06	6.96e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PPARG—thyroid cancer	7.83e-06	6.93e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—thyroid cancer	7.67e-06	6.79e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CCND1—thyroid cancer	7.66e-06	6.78e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—thyroid cancer	7.58e-06	6.71e-05	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—AKT1—thyroid cancer	7.55e-06	6.68e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTEN—thyroid cancer	7.39e-06	6.55e-05	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKT1—thyroid cancer	7.26e-06	6.43e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—thyroid cancer	7.11e-06	6.3e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PPARG—thyroid cancer	6.99e-06	6.19e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PPARG—thyroid cancer	6.82e-06	6.04e-05	CbGpPWpGaD
Progesterone—ABCC1—Disease—AKT1—thyroid cancer	6.77e-06	5.99e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—thyroid cancer	6.73e-06	5.96e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—thyroid cancer	6.72e-06	5.95e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—RXRA—thyroid cancer	6.66e-06	5.89e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—thyroid cancer	6.6e-06	5.84e-05	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—AKT1—thyroid cancer	6.55e-06	5.8e-05	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—AKT1—thyroid cancer	6.46e-06	5.72e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—thyroid cancer	6.44e-06	5.7e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PPARG—thyroid cancer	6.43e-06	5.69e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PPARG—thyroid cancer	6.37e-06	5.64e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTEN—thyroid cancer	6.2e-06	5.49e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—thyroid cancer	6.16e-06	5.45e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTEN—thyroid cancer	5.86e-06	5.19e-05	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKT1—thyroid cancer	5.69e-06	5.04e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—thyroid cancer	5.68e-06	5.03e-05	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—AKT1—thyroid cancer	5.67e-06	5.02e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—thyroid cancer	5.5e-06	4.87e-05	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—AKT1—thyroid cancer	5.48e-06	4.85e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PPARG—thyroid cancer	5.44e-06	4.82e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTEN—thyroid cancer	5.37e-06	4.76e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—thyroid cancer	5.37e-06	4.75e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—thyroid cancer	5.06e-06	4.48e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—thyroid cancer	5.05e-06	4.47e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—thyroid cancer	5.01e-06	4.44e-05	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—AKT1—thyroid cancer	4.94e-06	4.38e-05	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—AKT1—thyroid cancer	4.94e-06	4.37e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—thyroid cancer	4.83e-06	4.27e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTEN—thyroid cancer	4.79e-06	4.24e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTEN—thyroid cancer	4.68e-06	4.14e-05	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—AKT1—thyroid cancer	4.6e-06	4.07e-05	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—AKT1—thyroid cancer	4.53e-06	4.01e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTEN—thyroid cancer	4.41e-06	3.9e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTEN—thyroid cancer	4.37e-06	3.87e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—thyroid cancer	4.28e-06	3.79e-05	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKT1—thyroid cancer	4.26e-06	3.77e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PPARG—thyroid cancer	4.2e-06	3.72e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTEN—thyroid cancer	3.74e-06	3.31e-05	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—AKT1—thyroid cancer	3.57e-06	3.16e-05	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—AKT1—thyroid cancer	3.38e-06	2.99e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—thyroid cancer	3.31e-06	2.93e-05	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—AKT1—thyroid cancer	3.1e-06	2.74e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTEN—thyroid cancer	2.88e-06	2.55e-05	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—AKT1—thyroid cancer	2.76e-06	2.45e-05	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—AKT1—thyroid cancer	2.7e-06	2.39e-05	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—AKT1—thyroid cancer	2.54e-06	2.25e-05	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—AKT1—thyroid cancer	2.52e-06	2.23e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—AKT1—thyroid cancer	2.15e-06	1.91e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—AKT1—thyroid cancer	1.66e-06	1.47e-05	CbGpPWpGaD
